Bispecific T cell engager (BiTE(®)) antibody constructs can mediate bystander tumor cell killing

por Ross, Sandra L., Sherman, Marika, McElroy, Patricia L., Lofgren, Julie A., Moody, Gordon, Baeuerle, Patrick A., Coxon, Angela, Arvedson, Tara
Publicado 2017

MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways

por Saiki, Anne Y., Caenepeel, Sean, Yu, Dongyin, Lofgren, Julie A., Osgood, Tao, Robertson, Rebecca, Canon, Jude, Su, Cheng, Jones, Adrie, Zhao, Xiaoning, Deshpande, Chetan, Payton, Marc, Ledell, Jebediah, Hughes, Paul E., Oliner, Jonathan D.
Publicado 2014